What to watch with Pharmakogenetik Medicheck and gut health?

Combining pharmacogenetics (Medicheck) and gut health is an emerging area, but direct evidence remains limited. Pharmacogenetic tests analyze gene variants affecting drug metabolism (e.g., CYP450, MTHFR). Gut health – especially the microbiome – can modulate drug and nutrient absorption and metabolism. For instance, vitamin K2 (MK-7) is produced by gut bacteria; genetic variants in VDR or APOA2 (rs5082) may influence fat absorption. However, most pharmacogenetic recommendations are based on GWAS with small effect sizes and ancestry limitations. A key watchpoint: interactions between genes, gut flora, and medications vary greatly individually. Beware of overblown marketing claims – a test alone does not replace medical advice. It is prudent to consider gut health when taking anticoagulants (e.g., warfarin) or vitamin K-dependent processes. Evidence: mostly mechanistic and observational.